Johnson & Johnson
JNJ
$158.38
Share price
2.41%
Change (1 day)
-11.46%
Change (1 year)
Categories
Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.
Revenue for Johnson & Johnson (JNJ)
Revenue in 2023 (TTM): $91.32 B
According to Johnson & Johnson's latest financial reports the company's current revenue (TTM) is $91.32 B. In 2022 the company made a revenue of $94.94 B an increase over the years 2021 revenue that were of $93.77 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Johnson & Johnson from 2001 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $91.32 B | -3.81% |
| 2022 | $94.94 B | 1.25% |
| 2021 | $93.77 B | 13.55% |
| 2020 | $82.58 B | 0.64% |
| 2019 | $82.05 B | 0.59% |
| 2018 | $81.58 B | 6.71% |
| 2017 | $76.45 B | 6.34% |
| 2016 | $71.89 B | 2.59% |
| 2015 | $70.07 B | -5.73% |
| 2014 | $74.33 B | 4.23% |
| 2013 | $71.31 B | 6.08% |
| 2012 | $67.22 B | 3.37% |
| 2011 | $65.03 B | 5.59% |
| 2010 | $61.58 B | -0.5% |
| 2009 | $61.89 B | -2.9% |
| 2008 | $63.74 B | 4.34% |
| 2007 | $61.09 B | 14.57% |
| 2006 | $53.32 B | 5.56% |
| 2005 | $50.51 B | 6.69% |
| 2004 | $47.34 B | 13.1% |
| 2003 | $41.86 B | 15.33% |
| 2002 | $36.29 B | 10.75% |
| 2001 | $32.77 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $52.32 B | -42.70% | 🇨🇭 Switzerland |
 Pfizer PFE | $68.53 B | -24.95% | 🇺🇸 USA |
 Abbott Laboratories ABT | $39.95 B | -56.24% | 🇺🇸 USA |
 Medtronic MDT | $31.55 B | -65.44% | 🇮🇪 Ireland |
 Eli Lilly LLY | $32.07 B | -64.88% | 🇺🇸 USA |
 Sanofi SNY | $49.13 B | -46.19% | 🇫🇷 France |
 Gilead Sciences GILD | $27.39 B | -70.01% | 🇺🇸 USA |
 Stryker Corporation SYK | $19.88 B | -78.23% | 🇺🇸 USA |
 Merck MRK | $59.31 B | -35.05% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $36.53 B | -59.99% | 🇬🇧 UK |